Yuhan

Yuhan EBIT

The EBIT of Yuhan (000100.KS) as of Nov 3, 2026 is 229.91 B KRW. In the previous year, EBIT was 67.58 B KRW — a change of 240.20% (higher).

EBIT

229.91 BKRW

YoY

240.20%

Last updated:

In 2025, Yuhan's EBIT was 229.91 B KRW, a 240.20% increase from the 67.58 B KRW EBIT recorded in the previous year.

The Yuhan EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2021
48.60 B KRW
Jan 1, 2022
36.03 B KRW
Jan 1, 2023
57.03 B KRW
Jan 1, 2024
67.58 B KRW
Jan 1, 2025
229.91 B KRW
Jan 1, 2026 (e)
195.18 B KRW
Jan 1, 2027 (e)
253.11 B KRW
Jan 1, 2028 (e)
339.67 B KRW
The Yuhan EBIT history
YEAREBITYoY
est339.67 BKRW+34.19%
est253.11 BKRW+29.68%
est195.18 BKRW-15.11%
229.91 BKRW+240.20%
67.58 BKRW+18.49%
57.03 BKRW+58.30%
36.03 BKRW-25.86%
48.60 BKRW-42.32%
84.26 BKRW+572.12%
12.54 BKRW-74.99%
50.13 BKRW-43.49%
88.71 BKRW-9.29%
97.79 BKRW+13.93%
85.84 BKRW+15.38%
74.39 BKRW+20.30%
61.84 BKRW+78.73%
34.60 BKRW-34.39%
52.73 BKRW-36.19%
82.64 BKRW-4.29%
86.35 BKRW+4.07%
82.98 BKRW+15.83%
71.64 BKRW+8.32%
66.13 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yuhan Revenue

Yuhan Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
1.69 T KRW
48.60 B KRW
102.58 B KRW
Jan 1, 2022
1.78 T KRW
36.03 B KRW
95.14 B KRW
Jan 1, 2023
1.86 T KRW
57.03 B KRW
136.20 B KRW
Jan 1, 2024
2.07 T KRW
67.58 B KRW
70.69 B KRW
Jan 1, 2025
2.19 T KRW
229.91 B KRW
194.08 B KRW
Jan 1, 2026 (e)
2.33 T KRW
195.18 B KRW
157.06 B KRW
Jan 1, 2027 (e)
2.54 T KRW
253.11 B KRW
206.43 B KRW
Jan 1, 2028 (e)
2.82 T KRW
339.67 B KRW
280.19 B KRW

Yuhan Margins

Yuhan stock margins

The Yuhan margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Yuhan. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Yuhan.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
31.08 %
2.88 %
6.08 %
Jan 1, 2022
29.18 %
2.03 %
5.36 %
Jan 1, 2023
30.44 %
3.07 %
7.33 %
Jan 1, 2024
33.34 %
3.27 %
3.42 %
Jan 1, 2025
33.38 %
10.51 %
8.88 %
Jan 1, 2026 (e)
33.38 %
8.38 %
6.74 %
Jan 1, 2027 (e)
33.38 %
9.95 %
8.11 %
Jan 1, 2028 (e)
33.38 %
12.05 %
9.94 %

Yuhan Stock analysis

What does Yuhan do? The Yuhan Corporation is a South Korean conglomerate that was founded on September 1, 1926, under the name "Chosun Pharmaceutical Company". The company is headquartered in Seoul and employs more than 5,000 people worldwide. History: The Yuhan Corporation started as a small company with a single product, a fish oil-based ointment called "Yuksundo". The company worked hard to improve its products and expand its market, eventually expanding into other business areas such as the production of antibiotics and diabetes treatments. In the early 1950s, the company also ventured into the research and development of other pharmaceuticals. In 1962, Yuhan became a publicly traded company and received a variety of awards in the following years, including several Korean Industrial Awards. Since its inception, the company has remained committed to improving people's lives through innovation and science. Business model: The Yuhan Corporation is a pharmaceutical company that focuses on the development, manufacturing, and marketing of drugs and other health products. The company also makes investments in innovative technologies and healthcare startups. Over the years, Yuhan has expanded its business through partnerships with other companies and acquisitions of companies such as LGL Holdings and SillaJen Inc. The company also engages in international business relations, such as selling its products and medications in other countries. Divisions: The Yuhan Corporation has four main business divisions: Medical Research and Development, Drug Manufacturing, Biotechnology Product Development, and Health Product Production. The first division is coordinated by Yuhan Research & Development Co. Ltd, while drug manufacturing is done by Yuhan Manufacturing Co. Ltd. Biotechnology is done by Yuhan Biomedical Research Institute, and the health product segment is handled by Yuhan Healthcare. Products: Yuhan's products are diverse and include a wide range of drugs and health products. The company is involved in the production of antibiotics, analgesics, vein treatment agents, diabetes medications, cardiovascular drugs, and other pharmaceutical products. Other products also include cosmetics, oral care products, and dermatology drugs. Some of Yuhan's well-known products include the antibiotic Ceclor, a medication for the treatment of diabetes and metabolic disorders, as well as apple-based cosmetic products. All Yuhan products are manufactured according to strict quality standards and are known for their effectiveness and safety. Conclusion: The Yuhan Corporation has evolved into a diverse and innovative company focused on the production of drugs and health products. The company has a long history with many successes and has established itself as one of the major forces in the South Korean economy over the past decades. Yuhan's mission to create better healthcare remains as relevant today as it was at the time of its founding. Yuhan is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Yuhan's EBIT

Yuhan's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Yuhan's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Yuhan's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Yuhan’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Yuhan stock

EBIT of Yuhan is 229.91 B KRW in 2025.

EBIT of Yuhan changed from 67.58 B KRW to 229.91 B KRW, representing a 240.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Yuhan since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Yuhan historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Yuhan

All Key Metrics — Yuhan